• News
• Alerts
• Rankings & Awards
• Podcasts
• Resource Centers & Blogs
• Videos
• Events & Webinars

China SFDA Creates New Regulatory Pathways for Transfer of Drug Licenses

March 4, 2013 Practices: Life Sciences, China Life Sciences Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version